Safety and efficacy of sodium oligomannate in patients with Alzheimer’s disease: a systematic review and meta-analysis
Abstract Background We aim to evaluate the efficacy and safety of a new marine oligosaccharide drug, sodium oligomannate (GV-971), developed in China to treat Alzheimer’s disease (AD). Methods We researched the following databases: Embase, Web of Science, PubMed, Cochrane library, and Scopus until S...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SpringerOpen
2023-06-01
|
| Sarja: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s41983-023-00682-y |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|